Correlations between the genetic alterations and the metabolic and clinical phenotypes are based on the premise that the mRNA levels of MECP2 are decreased in patients with RTT and increased in subjects with MRXSL, as compared to controls. Here, MECP2 is linked to Rett syndrome.